Control Group | Ergocalciferol Group | p value Control vs ergo | |||||||
---|---|---|---|---|---|---|---|---|---|
Variable | Baseline | 6 months | 12 months | p for trend | Baseline | 6 months | 12 months | p for trend | |
Vitamin D level, ng/ml | 19.2 ± 6.8 | 19.7 ± 8.3 | 14.2 ± 9.3 | 0.002 | 16.2 ± 7.5 | 29.5 ± 9.9 | 30.6 ± 11.7 | <0.001 | <0.001 |
EPO dose, IU X 103/month | 26[12.3,49.4] | 23.9[9.7, 42.2] | 13[6.5,27] | 0.01 | 27.5[13.2, 48] | 26[16.4, 45.5] | 23.4[9.5, 39] | 0.02 | ns |
Hemoglobin, g/dl | 11.2 ± 1.1 | 11.4 ± 1 | 10.7 ± 1.3 | <0.001 | 11 ± 1.4 | 11.4 ± 1.5 | 10.9 ± 1.4 | 0.02 | ns |
TSAT, % | 27.5 ± 10.1 | 31.6 ± 12.6 | 29.9 ± 10.9 | 0.03 | 34.7 ± 18 | 32.5 ± 12.2 | 31.7 ± 13.9 | ns | 0.02 |
Ferritin, mg/dl | 538 ± 269 | 556 ± 260 | 614 ± 244 | 0.04 | 759 ± 425 | 691 ± 376 | 691 ± 370 | ns | 0.01 |
Albumin, mg/dl | 4.2 ± 0.4 | 4.2 ± 0.2 | 4.2 ± 0.3 | ns | 4 ± 0.3 | 4.1 ± 0.3 | 4.3 ± 0.6 | <0.001 | <0.001 |
Iron sucrose, mg/month | 260 ± 272 | 164 ± 151 | 199 ± 274 | 0.03 | 194 ± 231 | 180 ± 173 | 143 ± 162 | ns | ns |
Paricalcitol dose μg/month | 26 [10.5, 42] | 26[13, 51.5] | 39[23.5, 52] | 0.002 | 2512.5, 39] | 24[12, 39] | 20[9, 39] | ns | <0.001 |
Calcium, mg/dl | 9.2 ± 0.7 | 9.2 ± 0.7 | 9.3 ± 0.8 | ns | 9.1 ± 0.7 | 9.4 ± 0.7 | 9.1 ± 0.8 | <0.001 | <0.001 |
Phosphorus, mg/dl | 5.1 ± 1.4 | 5.6 ± 1.8 | 5.1 ± 1.3 | 0.01 | 5.3 ± 1.7 | 5.5 ± 1.7 | 5.7 ± 1.8 | ns | 0.03 |
PTH, pg/ml | 283[162, 408] | 253[151, 373] | 257[160, 429] | ns | 308[184, 490] | 263[145, 416] | 299[200, 471] | 0.01 | ns |
Hospitalization n/year (%) | 28 (35) | 37 (35) | ns |